Indication

Peyronie's disease

Peyronie's disease is an acquired connective tissue disorder of the male reproductive system characterized by the formation of fibrous collagen plaques within the tunica albuginea surrounding the erectile tissue of the penis. Read more about Peyronie's disease

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Peyronie's disease therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Peyronie's disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Peyronie's disease.

Peyronie's disease is an acquired connective tissue disorder of the male reproductive system characterized by the formation of fibrous collagen plaques within the tunica albuginea surrounding the erectile tissue of the penis.

Pathophysiologically, it typically stems from microvascular trauma or aberrant wound healing, leading to localized inflammation and unyielding scar tissue that impairs uniform tissue expansion during erection.

Clinically, it manifests in adult men as palpable penile induration, painful erections, and structural deformities such as curvature, indentation, or shortening, which can cause erectile dysfunction and impede sexual intercourse.

The clinical course typically progresses from an active, inflammatory phase marked by evolving deformity and pain to a chronic, stable phase where the fibrotic plaques often calcify and curvature stabilizes.

Personalize your experience

Follow Peyronie's disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it